• Symposia

     
     
     
    Type Size
     

    Friday, October 12


    Symposium – Fracture Healing
    11:30 - 1:00 pm


    Co-Chairs:
    Susan Bukata, M.D., UCLA (USA)
    Mary Bouxsein, Ph.D., Beth Israel Deaconess Medical Center (USA)

    Parathyroid Hormone
    Per Aspenberg, M.D., Linkoping University (Sweden)


    Sclerostin Antibody

    Michael Ominsky, Ph.D., Amgen Inc. (USA)


    Bone Morphogenic Proteins
    Gary Friedlaender, M.D., Yale School of Medicine (USA)


    Symposium – Regulation of Mesenchymal Stem Cells
    11:30 am – 1:00 pm

    Supported by an educational grant from Merck & Co, Inc.


    Co-Chairs:
    Darwin Prockop, M.D., Ph.D., Texas A&M Health Science Center (USA)
    Cun-Yu Wang, Ph.D., D.D.S., UCLA (USA)

    Flexible Bones: Integrated vs. Differential Control of Stem Cells and Lineages in the Stromal System
    Paolo Bianco, M.D., Universita La Sapienza (Italy)

    The Wnt/Planar Cell Polarity Pathway Regulates Directional Skeletal Morphogenesis
    Yingzi Yang, Ph.D., National Institute of Health (USA)

    Adult Stem Cell Biology: A Tale of Ovaries, Menopause and Their Impact on Bone Health
    Jonathan Tilly, Ph.D., Harvard Medical School (USA)

     

    Symposium – Regulation of Bone Through TGF-β Super Family Receptors
    1:30 pm – 3:00 pm

    Supported by an educational grant from Merck & Co, Inc.

    Co-Chairs:
    Roland Baron, D.D.S., Ph.D., Harvard School of Medicine and of Dental Medicine (USA)
    Di Chen, M.D., Ph.D., Rush University Medical Center (USA)

    The Role of TG F-β in Osteoarthritis
    Wim van den Berg, Ph.D., Radboud University Nijmegen Medical Centre (The Netherlands)

    BMP Signaling in Bone Development and Repair
    Vicki Rosen, Ph.D., Harvard School of Dental Medicine (USA)

    TG F-β1 in Subchordral Bone Remodeling and Osteoarthritis
    Xu Cao, Ph.D., Johns Hopkins University (USA)

    Symposium- Fracture Risk Assessment
    1:30 pm – 3:00 pm

    Co-Chairs:
    Ghada El-Hajj Fuleihan, M.D., MPH, American University of Beirut-Medical Center (Lebanon)
    John Schousboe, M.D., Ph.D., Park Nicollet Clinic, University of Minnesota (USA)

    FRAX
    Bess Dawson-Hughes, M.D., Tufts University (USA)

    Other Fracture Risk Calculators
    William Leslie, M.D., MSc, FRCP, University of Manitoba (Canada)

    Beyond Risk Calculators: Back to Clinical Judgment
    Michael McClung, M.D., Oregon Osteoporosis Center (USA)


    State-of-the-Art Lectures – Bone-muscle Interactions during Development
    3:15 pm – 4:45 pm

    Co-Sponsored by the European CalcifiedTissue Society (ECTS)

    Co-Chairs:
    Thomas Clemens, Ph.D., Johns Hopkins University (USA)
    Karyn Esser, Ph.D., University of Kentucky (USA)

    Muscle and Connective Tissue Interactions during Development and Regeneration
    Gabrielle Kardon, Ph.D., University of Utah (USA)

    Tissue Interactions in the Developing Limb Musculoskeletal System
    Malcolm Logan, Ph.D., MRC, National Institute for Medical Research (United Kingdom)

    Muscle-Induced Mechanical Loads Regulate Key Aspects of Skeletogenesis
    Elazar Zelzer, Ph.D., Weizmann Institute of Science (Israel)

     

    Saturday, October 13

     

    State-of-the-Art Lectures – MSCs, HSC, Vasculature Interactions
    4:00 pm – 5:30 pm

    Supported by an educational grant from Lilly USA, LLC

    Co-Chairs:
    Cliff Rosen, M.D., Maine Medical Center (USA)
    Xuedong Zhou, Ph.D., D.D.S., SiChuan University (China)

    Vascular Endothelial and Mesenchymal Stem Cells in Bone Formation
    Bjorn Olsen, M.D., Ph.D., Harvard School of Dental Medicine (USA)

    Endocrine Regulation of the Bone Vascular Axis
    Dwight Towler, M.D., Ph.D., Washington University in St. Louis (USA)

    Smooth Muscle Cell Plasticity and Vascular Disease
    Catherine Shanahan, Ph.D., Kings College London (United Kingdom)


    Symposium – Duration and Safety of Osteoporosis Therapy
    4:00 pm – 5:30 pm

    Co-Chairs:
    Stuart Silverman, M.D., Cedars-Sinai/UCLA (USA)
    Bo Abrahamsen, M.D., Ph.D., Copenhagen University Hospital Gentofte (Denmark)

    Osteonecrosis of the Jaw
    John Hellstein, D.D.S., M.S., University of Iowa (USA)

    Atypical Femoral Fractures
    Regis O’Keefe, M.D., University of Rochester (USA)

    Length of Osteoporosis Treatment – What Is the Evidence?
    Nelson Watts, M.D., University of Cincinnati Bone Health and Osteoporosis Center (USA)

    Plenary Symposium – Steroid Hormonal Regulation of Bone
    8:00 am – 9:30 am

    Supported by an educational grant from Lilly USA, LLC

    Co-Chairs:
    Henry Kronenberg, M.D., Massachusetts General Hospital (USA)
    Mei Wan, M.D., Ph.D., Johns Hopkins University School of Medicine (USA)

    Steroid Receptor Coactivators: Keys to Mechanism of Action
    Bert O’Malley, M.D., Baylor College of Medicine (USA)

    Skeletal Interactions between Glycoprotein and Steroid Hormones
    Mone Zaidi, M.B.B.S., Ph.D., Mount Sinai Medical Center (USA)

    Gene Transcription Regulation and Bone
    Shigeaki Kato, Ph.D., University of Tokyo (Japan)


    State-of-the-Art Lectures – Matricellular Signaling
    4:30 pm – 6:00 pm

    Supported by an educational grant from Merck & Co, Inc.

    Co-Chairs:
    Sundeep Khosla, M.D., Mayo Clinic (USA)
    Laurie McCauley, D.D.S., Ph.D., University of Michigan School of Dentistry (USA)

    Communication among Bone Cells

    Hiroshi Takayanagi, M.D., Ph.D., Tokyo Medical and Dental University (Japan)

    Matrix Elasticity Controls Fate of MSCs
    Dennis Discher, Ph.D., University of Pennsylvania (USA)

    The Osteoclast and its Unique Cytoskeleton
    Steven Teitelbaum, M.D., Washington University in St. Louis School of Medicine (USA)


    Symposium – The Aging Kidney, Osteoporosis and Vascular Calcification
    4:30 pm – 6:00 pm

    Chair:
    Paul Miller, M.D., FACP, Colorado Center for Bone Research (USA)

    Age-related Kidney Disease – Implications for Disturbed Mineral Metabolism and Bone Disease
    Moshe Levi, M.D., University of Colorado Denver (USA)

    Mineral Dysregulation in CKD, an Accelerated Model of Aging
    Susan Schiavi, Ph.D., M.S., Genzyme Corporation (USA)

    Emerging Roles of FGF23 as a Bridge between Phosphate and Iron Metabolism in the Bone-kidney Endocrine Axis
    Kenneth White, Ph.D., Indiana University School of Medicine (USA)

    AGEs and Aging Bone Lesions in Mice
    Gary Striker, M.D., Mount Sinai School of Medicine (USA)


    Sunday, October 14

     

    Plenary Symposium – Bone Turnover Markers
    8:00 am – 9:30 am

    Supported by an educational grant from Lilly USA, LLC

    Sponsored by the ASBMR Professional Practice Committee

    Co-Chairs:
    Markus Seibel, M.D., Ph.D., ANZAC Research Institute, University of Sydney (Australia)
    Michael Lewiecki, M.D., FACP, FACE, University of New Mexico School of Medicine (USA)


    Novel Markers of Bone Metabolism
    Patrick Garnero, Ph.D., INSERM Research Unit 664 and Cisbio Bioassays (France)

    Novel Osteoporosis Therapies and their Effects on Markers of Bone Metabolism
    Kristina Åkesson, M.D., Ph.D., Skåne University Hospital, Malmö (Sweden)

    How to Improve the Clinical Utility of Bone Turnover Markers
    Douglas Bauer, M.D., University of California, San Francisco (USA)


    Symposium – Osteoarthritis and the Skeleton
    1:30 pm – 2:30 pm

    Co-sponsored with The Osteoarthritis Research Society International (OARSI)

    Co-chairs:
    Marc Hochberg, M.D., University of Maryland School of Medicine (USA)
    Mary Goldring, Ph.D., Hospital for Special Surgery (USA)

    The Role of Subchondral Bone in Osteoarthritis
    David Burr, Ph.D., Indiana University School of Medicine (USA)

    New Directions in Treatment of Osteoarthritis: Mouse Models
    Edward Schwarz, Ph.D., University of Rochester (USA)

    Hip Shape, Genetics and Osteoarthritis
    Nancy Lane, M.D., University of California, Davis Medical Center (USA)